MarketCapTrends
AQST
Aquestive Therapeutics Inc. (AQST)
NASDAQ

Aquestive Therapeutics Inc. Cash on Hand 2017–2025

Aquestive Therapeutics Inc. annual/quarterly cash on hand history from 2017 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Aquestive Therapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 121.2M, a 69.36% increase year-over-year.
  • Aquestive Therapeutics Inc. cash on hand for 2025 were 121.2M, a 69.36% increase from 2024.
  • Aquestive Therapeutics Inc. cash on hand for 2024 were 71.5M, a 199.71% increase from 2023.
  • Aquestive Therapeutics Inc. cash on hand for 2023 were 23.9M, a 12.47% decrease from 2022.
  • Aquestive Therapeutics Inc. cash on hand for 2022 were 27.3M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Aquestive Therapeutics Inc. Annual Cash on Hand (Millions of US $)
2025$121
2024$72
2023$24
2022$27
2021$28
2020$32
2019$49
2018$61
2017$17
Aquestive Therapeutics Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$121
2024-12-31$72
2023-12-31$24
2022-12-31$27
2021-12-31$28
2020-12-31$32
2019-12-31$49
2018-12-31$61
2017-12-31$17

Aquestive Therapeutics Inc. Cash on Hand — FAQ

Aquestive Therapeutics Inc. (AQST) cash on hand over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see AQST's cash on hand history?

The chart and table above show Aquestive Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.